PepGen

PepGen R&D Expenses

The Research & Development Expenses of PepGen (PEPG) as of Nov 19, 2026 is 71.04 M USD. In the previous year, Research & Development Expenses was 76.48 M USD — a change of -7.11% (lower).

R&D Expenses

71.04 MUSD

YoY

-7.11%

Last updated:

Research & Development Expenses of PepGen is 2025 71.04 M USD. Research & Development Expenses of PepGen was 2024 76.48 M USD. It decreases by -7.11% lower compared to the previous year.

The PepGen R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2019
620,000.00 USD
Jan 1, 2020
1.12 M USD
Jan 1, 2021
23.80 M USD
Jan 1, 2022
54.08 M USD
Jan 1, 2023
68.13 M USD
Jan 1, 2024
76.48 M USD
Jan 1, 2025
71.04 M USD
The PepGen R&D Expenses history
YEARR&D ExpensesYoY
71.04 MUSD-7.11%
76.48 MUSD+12.26%
68.13 MUSD+25.98%
54.08 MUSD+127.22%
23.80 MUSD+2,017.35%
1.12 MUSD+81.29%
620,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

Research & Development Expenses of PepGen is 71.04 M USD in 2025.

Research & Development Expenses of PepGen changed from 76.48 M USD to 71.04 M USD, representing a -7.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses PepGen since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's PepGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — PepGen

All Key Metrics — PepGen